drugset / Trial / NCT02751632
The Staged Treatment in Early Psychosis Study
Phase 3
Completed
342 enrolled
Orygen
National Institute of Mental Health (NIMH) · collabUniversity of California, Davis · collabUniversity of California, San Francisco · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
A sequential multistage randomised clinical trial (SMART) to produce evidence to guide a step-wise clinical approach for the treatment of ultra high risk patients and reduction of risk for psychosis and other deleterious clinical and/or functional outcomes.
Timeline
- Start
- 2016-04
- Primary completion
- 2019-07
- Completion
- 2022-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | 20 mg | — |
| Subject | Fluoxetine | Small molecule | 40 mg | — |